NASDAQ: AKRO - Akero Therapeutics, Inc.

Yield per half year: +29.09%
Sector: Healthcare

Share chart Akero Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Akero Therapeutics, Inc., компания, занимающаяся кардиометаболическим неалкогольным стеатогепатитом (НАСГ), занимается разработкой лекарственных средств, предназначенных для восстановления метаболического баланса и улучшения общего состояния здоровья. Ведущим продуктом компании является эфруксифермин (EFX), аналог фактора роста фибробластов 21, который защищает от клеточного стресса и регулирует метаболизм липидов, углеводов и белков во всем организме.

more details
Он также проводит клиническое исследование фазы 2а, исследование BALANCED, для оценки EFX в лечении пациентов с НАСГ, подтвержденным биопсией. Ранее компания называлась Pippin Pharmaceuticals, Inc., а в мае 2018 года сменила название на Akero Therapeutics, Inc.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA -0.0457
EV/EBITDA -3.34
IPO date 2019-06-20
ISIN US00973Y1082
Industry Biotechnology
P/BV 2.24
P/E 8.18
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.akerotx.com
Цена ао 31.73
Число акций ао 0.05257 млрд
Change price per day: 0% (28.89)
Change price per week: -1.53% (29.34)
Change price per month: -10.2% (32.17)
Change price per 3 month: +2.3% (28.24)
Change price per half year: +29.09% (22.38)
Change price per year: +23.73% (23.35)
Change price per 3 year: +64.9% (17.52)
Change price per 5 year: +17.01% (24.69)
Change price per 10 year: 0% (28.89)
Change price per year to date: -1.53% (29.34)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 2.33 6
P/E 8.18 9
EV/EBITDA -6.01 0
Total: 5

Efficiency

Title Value Grade
ROA, % -26.15 0
ROE, % -28.35 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1459 10
Total: 7.6

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 225.58 10
Yield EPS, % -0.5652 0
Total: 6
More

Institutions Volume Share, %
State Street Corporation 5122895 9.1
Janus Henderson Group PLC 4306401 7.65
Blackrock Inc. 4180507 7.43
Alkeon Capital Management LLC 3764220 6.69
Price (T.Rowe) Associates Inc 3675924 6.53
RTW Investments LP 3592759 6.38
Vanguard Group Inc 3085048 5.48
Wellington Management Group, LLP 2881989 5.12
Baker Brothers Advisors, LLC 2368378 4.21
Yiheng Capital Management, L.P. 1923674 3.42

ETF Share, % Profitability for 1 year, % Dividends, %
Invesco Dorsey Wright Healthcare Momentum ETF 1.37645 2.8 0.12263
Virtus LifeSci Biotech Clinical Trials ETF 0.90264 63.04 0.33
Simplify Health Care ETF 0.62222 27.81 1.00373
Direxion Daily S&P Biotech Bull 3x Shares 0.2749 4067.92 0.25924
Future Tech ETF 0.18836 426.34 0.8416
Principal Healthcare Innovators ETF 0.18836 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.18626 28.58 0.8565
ProShares Ultra Nasdaq Biotechnology 0.1239 51.7 0.85651
Avantis U.S Small Cap Equity ETF 0.1219 27.77 1.68271
Vanguard Russell 2000 Value ETF 0.12 4.69 2.37825
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.10273 24.75 1.59225
Vanguard Russell 2000 ETF 0.07 10.65 1.48801
Schwab U.S. Small-Cap ETF 0.04937 9.77 1.51433
ProShares UltraPro Russell2000 0.04112 89.82 1.47873
iShares Morningstar Small-Cap Growth ETF 0.03636 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.03636 598.05 0.72598
iShares Morningstar Small-Cap ETF 0.034 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.034 30.1 1.60498
iShares Morningstar Small Cap Value ETF 0.03094 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.03094 191.18 2.50476
iShares Russell 2000 Growth ETF 0.024 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.02 14.28 0.60264
Fidelity MSCI Health Care Index ETF 0.01957 2.06 1.46057
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.01693 11.83 1.75869
FlexShares Morningstar US Market Factor Tilt Index Fund 0.01186 19.33 1.69572
ProShares Hedge Replication ETF 0.01115 5.92 1.47892
SPDR Portfolio MSCI Global Stock Market ETF 0.01046 15.31 2.19607
Humankind US Stock ETF 0.00691 18.81 1.99919
iShares Russell 3000 ETF 0.00385 23.53 1.43482
Avantis U.S. Equity ETF 0.0037 19.28 1.59151
Schwab U.S. Broad Market ETF 0.00328 23.81 1.43354
Vanguard ESG U.S. Stock ETF 0 25.55 1.26927
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Dr. Jonathan M. Young J.D., Ph.D. Co-Founder, Executive VP, COO & Secretary 763.3k 1970 (55 years)
Dr. Timothy Rolph Co-Founder & Chief Scientific Officer 819.4k 1954 (71 year)
Mr. William R. White J.D. Executive VP, CFO, Treasurer & Head of Corporate Development 768.4k 1973 (52 years)
Ms. Catriona Yale Executive VP & Chief Development Officer 754.8k 1972 (53 years)
Mr. John J. Schembri Senior VP & Head of Finance N/A 1962 (63 years)
Mr. Patrick Lamy Senior Vice President of Commercial Strategy N/A 1973 (52 years)
Dr. Andrew Cheng M.D., Ph.D. President, CEO & Director 1967 (58 years)
Mr. Scott A. Gangloff Chief Technical Officer 1974 (51 year)
Mr. David West J.D. Vice President of Legal

Address: United States, South San Francisco. CA, 601 Gateway Boulevard - open in Google maps, open in Yandex maps
Website: https://www.akerotx.com